Latest Regulatory News

Ardea Resources has extended its Major Project Status for the Kalgoorlie Nickel Project, reinforcing its strategic role in Australia's critical minerals sector and ensuring continued government support.

Immutep Limited’s Phase II trial of eftilagimod alfa combined with radiotherapy and KEYTRUDA in soft tissue sarcoma patients has exceeded its primary endpoint, showing a 51.5% median tumor hyalinization rate, more than triple the historical standard. These promising results, presented at ESMO 2025, suggest a potential breakthrough in a challenging cancer indication.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

BlackRock Investment Management (Australia) Limited has announced final cash distributions for its iShares Balanced ESG ETF and High Growth ESG ETF, detailing payment schedules and reinvestment options for investors.

Vault Minerals Limited has announced a significant security consolidation, reducing its ordinary shares and performance rights by a factor of more than six. The move, effective from mid-November, aims to streamline the company’s capital structure ahead of resumed trading.

Prominence Energy has achieved a pivotal milestone with the award of Petroleum Exploration Licence 803 for its Gawler Hydrogen Project, positioning itself as a key player in Australia's emerging natural hydrogen sector. The company also strengthened its leadership team and completed a $1.75 million capital raise to fund its growth ambitions.

Multistack International Limited has announced plans to discontinue its current business operations due to sustained losses and capital constraints, with a strategic disposal of its Australian subsidiary underway.

Multistack International Limited reported a net operating cash outflow of A$180,348 for the September quarter but maintains robust cash reserves of A$1.33 million. The company is planning a strategic disposal of its shares in Multistack Australia, signaling a potential shift in its operational focus.

WAM Income Maximiser Limited is offering eligible shareholders the chance to buy up to $30,000 in shares at a discount, aiming to raise $48.1 million to fuel growth and support monthly dividends.

Iluka Resources has withdrawn its synthetic rutile sales guidance due to uncertainties stemming from Venator's sale and idling of its Greatham titanium dioxide facility. The move highlights growing market challenges and contract renegotiations in the pigment sector.

Hawk Resources has raised A$5 million and secured an option to earn up to 80% of the Olympus Scandium Project in Western Australia, aiming to advance exploration of a large-scale scandium anomaly in a Tier-1 jurisdiction.

Talga Group has won a SEK 82.6 million (A$13.3 million) grant from the Swedish Energy Agency to advance its low-emission graphite anode project, accelerating its path to commercial-scale production in Sweden.